{"nctId":"NCT00552409","briefTitle":"Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease","startDateStruct":{"date":"2007-12"},"conditions":["Diabetes Mellitus","Chronic Kidney Disease","Diabetic Kidney Disease"],"count":22,"armGroups":[{"label":"Cholecalciferol","type":"EXPERIMENTAL","interventionNames":["Dietary Supplement: Cholecalciferol"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Dietary Supplement: Placebo"]}],"interventions":[{"name":"Cholecalciferol","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Clinical diagnosis of type 2 diabetes mellitus\n* Urine albumin-creatinine ratio 30-1000 mg/g\n* Estimated glomerular filtration rate greater than or equal to 60 mL/min\n* Treatment with angiotensin converting enzyme inhibitor and/or angiotensin II receptor blocker for greater than or equal to 6 months, with a stable dose for greater than or equal to 3 months\n* Blood pressure less than 140/90 (assessed while taking medications)\n* Hemoglobin A1c less than 9% (assessed while taking medications)\n* 25-hydroxyvitamin D less than 30 ng/mL\n\nExclusion Criteria:\n\n* Prior dialysis or kidney transplantation\n* Known cause of albuminuria other than diabetes\n* Planning to leave the area within 12 months\n* Life expectancy less than 12 months\n* Participation in another clinical trial within 6 months\n* Osteoporosis or other established indication for vitamin D therapy\n* Vitamin D3 supplement intake greater than 400 IU/day at screening visit\n* History of nephrolithiasis\n* Serum calcium greater than 10.2 mg/dL\n* Dementia, not fluent in English, or unable to provide informed consent without proxy respondent\n* Incontinent of urine\n* Failure to take greater than or equal to 80% of placebo pills during study run-in","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Urine Albumin Excretion","description":"Albumin and creatinine concentrations were measured in 24hr urine collections at baseline, 3 months after randomization, and one year after randomization. We analyzed the difference in log-transformed albumin-creatinine ratio (ACR, mg/g) after randomization (3 months and one year, analyzed together with all available data included) compared with baseline, by treatment assignment. Results are transformed to present percent difference in urine ACR.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-21","spread":null},{"groupId":"OG001","value":"-5","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":11},"commonTop":["upper respiratory infection","cough","edema","shoulder pain","decreased mood"]}}}